Fmoc-L-His(Mmt)-OH is an Fmoc-protected, L-histidine-derived amino acid derivative bearing an Mmt (2,2,4,6,7-pentamethyl-dihydrobenzofuran-5-sulfonyl) protecting group on the imidazole side chain. The molecule includes an Fmoc carbamate on the α-amino group and a free carboxylic acid, while the imidazole nitrogen is masked by the sulfonyl sulfonamide-type Mmt group to modulate side-chain chemoselectivity during peptide assembly. It is used as a building block in stepwise peptide synthesis, including solid-phase peptide synthesis workflows, where orthogonal protection of the histidine side chain supports controlled coupling and minimizes undesired side reactions from the unprotected imidazole.
CAT No: CP25318
CAS No:133367-33-6
Synonyms/Alias:133367-33-6;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-((4-methoxyphenyl)diphenylmethyl)-1H-imidazol-4-yl)propanoicacid;AmbotzFAA1070;CTK8B7901;MolPort-008-267-632;ANW-58899;CF-801;AKOS015903929;ZINC150339634;AK-58062;KB-210811;RT-004515;FT-0629898;I14-18128
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-im-p-methoxytrityl-L-histidine
Fmoc-L-His(Mmt)-OH is an Fmoc-protected L-histidine derivative bearing a side-chain Nτ-methyltrityl (Mmt) protecting group on the imidazole nitrogen. The molecule combines a stereodefined α-amino acid backbone with an Fmoc carbamate at the nitrogen, while the carboxylic acid remains available for standard peptide coupling chemistry. The histidine imidazole ring is sterically masked by the Mmt group, reducing undesired side reactions during chain assembly while preserving a defined histidine functionality for later unmasking. The presence of the chiral center and orthogonally protected side-chain nitrogen supports controlled peptide synthesis, fragment derivatization, and downstream functionalization strategies that rely on histidine's unique metal-binding and protonation behavior.
1. Peptide Synthesis
Fmoc-L-His(Mmt)-OH is used as a protected histidine peptide building block in solid-phase peptide synthesis and solution-phase peptide coupling workflows where selective N- and side-chain protection is required. The Fmoc group enables iterative N-terminal deprotection under basic conditions, while the Mmt-protected imidazole nitrogen suppresses side-chain participation in coupling and minimizes cross-reactivity during amide bond formation. The free carboxylic acid supports activation and coupling to form stable peptide bonds with controlled incorporation of the L-histidine stereochemistry. Unmasking of the Mmt group at the appropriate stage can regenerate the imidazole functionality for histidine-containing sequences, including peptides intended for metal coordination studies and pH-dependent structural probes. The compound therefore functions as a structurally defined intermediate for constructing histidine-rich peptide motifs with orthogonal protection logic.
2. Chemical Biology
Fmoc-L-His(Mmt)-OH is applied in chemical biology workflows that require site-defined histidine residues for studying protein-ligand recognition, metal binding, and pH-responsive behavior. The protected imidazole in the side chain allows controlled synthesis of histidine-bearing peptides or peptide mimetics without premature imidazole reactivity, while the Fmoc handle supports incorporation into longer constructs. After selective deprotection, the regenerated histidine side chain can participate in coordination chemistry with metal ions or serve as a chemical handle for downstream derivatization strategies targeting imidazole chemistry. The stereochemical fidelity of the L-histidine backbone helps maintain realistic local geometry in peptide scaffolds used for biochemical recognition assays. Such use aligns amino acid derivatization with peptide science needs for reproducible functional group presentation.
3. Bioconjugation Chemistry
Fmoc-L-His(Mmt)-OH can serve as a precursor for bioconjugation reagents and conjugation-ready peptide segments where histidine side chains are required as coordination or attachment points. The Mmt-protected imidazole nitrogen supports synthesis of conjugation scaffolds that remain stable during coupling chemistry and purification steps, while later removal can expose an imidazole capable of interacting with metal-chelating tags or participating in controlled post-synthetic functionalization. The Fmoc-protected amino terminus enables assembly of defined conjugate linkers, including those that present histidine at a specific position relative to other functional groups. The resulting histidine-containing intermediates can be used to generate conjugates for analytical binding studies, affinity capture formats, or structure-defined labeling reagents. This approach leverages orthogonal protection to align amino acid synthesis with downstream conjugation design.
4. Peptidomimetics And SAR Studies
Fmoc-L-His(Mmt)-OH is suitable for building histidine-containing peptidomimetic libraries and structure-activity relationship (SAR) study scaffolds where controlled side-chain exposure is essential. The orthogonally protected imidazole and Fmoc-protected α-amino group allow sequential construction of analogs that incorporate histidine in a stereochemically defined manner, supporting reproducible comparisons across analog series. The protected side chain can be unmasked to enable imidazole-mediated interactions that influence binding modes, protonation states, and conformational preferences in peptide-like molecules. The carboxylic acid functionality supports conversion into activated intermediates for coupling to non-peptidic fragments or for assembling hybrid scaffolds used in medicinal chemistry screening. Use of Fmoc-L-His(Mmt)-OH therefore supports systematic derivatization strategies that connect amino acid protection chemistry to SAR-oriented molecular design.
5. Pharmaceutical Manufacturing Intermediates
Fmoc-L-His(Mmt)-OH is relevant to pharmaceutical manufacturing contexts that involve peptide or peptide-like intermediate preparation under controlled, scalable synthetic conditions. The Fmoc-protected amino group is compatible with established peptide synthesis protection/deprotection cycles, while the Mmt side-chain protection helps prevent imidazole-related side reactions that can complicate impurity profiles during manufacturing. The defined L-histidine stereocenter and the orthogonal protection scheme support reproducible incorporation of histidine residues into drug substance intermediates and processable peptide intermediates. The compound's carboxylic acid enables formation of activated coupling species for constructing longer sequences or for preparing key intermediates used in downstream purification and analytical characterization. This makes Fmoc-L-His(Mmt)-OH a practical amino acid derivative for process chemistry routes that require robust protection-group behavior and predictable peptide coupling compatibility.
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.